Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
GMED
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+26%
0.53
vs 0.42
Q2.23
+13%
0.63
vs 0.56
Q3.23
+14%
0.57
vs 0.5
Q4.23
+2%
0.6
vs 0.59
Q1.24
+36%
0.72
vs 0.53
Q2.24
+19%
0.75
vs 0.63
Q3.24
+46%
0.83
vs 0.57
Q4.24
+40%
0.84
vs 0.6
Q1.25
+3%
0.74
vs 0.72
Q2.25
+13%
0.84
vs 0.75
Sales Growth
YoY
Current
Estimates
Q1.23
+20%
276.7M vs 230.5M
Q2.23
+11%
291.6M vs 263.6M
Q3.23
+51%
383.6M vs 254.1M
Q4.23
+125%
616.5M vs 274.5M
Q1.24
+119%
606.7M vs 276.7M
Q2.24
+116%
629.7M vs 291.6M
Q3.24
+63%
625.7M vs 383.6M
Q4.24
+7%
657.3M vs 616.5M
Q1.25
+3%
625.9M vs 606.7M
Q2.25
+8%
678.5M vs 629.7M
Return on Equity
QoQ
Q1.23
+3%
0.03
vs 0.03
Q2.23
+3%
0.03
vs 0.03
Q3.23
+0%
0
vs 0.03
Q4.23
+0%
0
vs 0
Q1.24
0%
-0.00
vs 0
Q2.24
+1%
0.01
vs -0.00
Q3.24
+1%
0.01
vs 0.01
Q4.24
+1%
0.01
vs 0.01
Institutionnal Ownership
QoQ
Q1.23
401
401
vs 394
2%
Q2.23
389
389
vs 401
-3%
Q3.23
437
437
vs 389
12%
Q4.23
418
418
vs 437
-4%
Q1.24
447
447
vs 418
7%
Q2.24
454
454
vs 447
2%
Q3.24
456
456
vs 454
0%
Q4.24
507
507
vs 456
11%
zacks.com
9 hours ago
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
13 hours ago
zacks.com
13 hours ago
globenewswire.com
16 hours ago
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
BTIG
upgradePrevious: Not converted
2024-03-18
Now: Buy
Canaccord Genuity
upgradePrevious: Not converted
2023-03-30
Now: Buy
CFRA
upgradePrevious: Not converted
2023-02-09
Now: Hold
Relative Strength
GMED
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Quote Panel
Key Metrics